French law enforcement and health insurance authorities have been investigating a significant fraud scheme targeting the medical transport sector, in which operators allegedly overbilled the national health insurance system (Assurance Maladie) for ambulance and patient transport services. Investigations have pointed to networks that systematically inflated invoices or billed for services never rendered, siphoning millions of euros from public health funds.
According to French judicial and health insurance sources, proceeds from these fraudulent billing schemes were allegedly laundered through real estate investments in Morocco, a pattern that investigators say has been observed across multiple cases involving organized networks with cross-border ties. The Assurance Maladie has identified medical transport as one of the most fraud-prone sectors within the French healthcare reimbursement system.
French authorities, including the DNLF (DΓ©lΓ©gation Nationale Γ la Lutte contre la Fraude) and health insurance fraud units, have stepped up controls on transport sanitaire operators in recent years. Fraudulent practices identified include ghost trips, falsified patient signatures, and the use of shell companies to multiply reimbursement claims. The total cost of healthcare fraud in France is estimated by official bodies at several billion euros annually, with transport representing a disproportionate share.
Suspects in such cases typically face charges of organized fraud, money laundering, and misuse of public funds under French law. Convictions can carry sentences of up to ten years in prison and substantial financial penalties. Authorities have called for stronger digital tracking of patient transport to reduce opportunities for abuse.
